tiprankstipranks
Trending News
More News >
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market

AstraZeneca Pharma India Limited (ASTRAZEN) Income Statement

Compare
27 Followers

AstraZeneca Pharma India Limited Income Statement

Last quarter (Q1 2026), AstraZeneca Pharma India Limited's total revenue was ₹5.26B, an increase of 35.81% from the same quarter last year. In Q1, AstraZeneca Pharma India Limited's net income was ₹558.30M. See AstraZeneca Pharma India Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 17.16B₹ 12.96B₹ 10.03B₹ 8.06B₹ 8.09B
Gross Profit
₹ 7.53B₹ 6.22B₹ 5.78B₹ 4.48B₹ 4.78B
Operating Expenses
₹ 5.39B₹ 4.51B₹ 4.29B₹ 3.78B₹ 3.62B
Depreciation and Amortization
₹ 399.90M₹ 149.40M₹ 162.60M₹ 169.50M₹ 197.50M
EBITDA
₹ 1.98B₹ 2.36B₹ 1.51B₹ 1.01B₹ 1.48B
Operating Income
₹ 2.14B₹ 1.71B₹ 1.49B₹ 696.50M₹ 1.16B
Other Income/Expenses
₹ -576.20M₹ 481.10M₹ -147.90M₹ 133.90M₹ 108.30M
Pretax Income
₹ 1.56B₹ 2.20B₹ 1.34B₹ 830.40M₹ 1.27B
Net Income
₹ 1.16B₹ 1.62B₹ 992.90M₹ 616.00M₹ 933.00M
Per Share Metrics
Basic EPS
₹ 46.30₹ 64.60₹ 39.72₹ 24.64₹ 37.32
Diluted EPS
₹ 46.30₹ 64.60₹ 39.72₹ 24.64₹ 37.32
Weighted Average Shares Outstanding
25.00M 25.00M 25.00M 25.00M 25.00M
Weighted Average Shares Outstanding (Diluted)
25.00M 25.00M 25.00M 25.00M 25.00M
Currency in INR

AstraZeneca Pharma India Limited Earnings and Revenue History